Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Encompass Health Corporation (EHC) Tops Q4 EPS by 4c, Offers Guidance
February 7, 2023 4:41 PM ESTEncompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.88, $0.04 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.12 billion.
GUIDANCE:
Encompass Health Corporation sees FY2023 EPS of $2.87-$3.16, versus the consensus... More
